NCT00599118View on ClinicalTrials.gov

Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation

Active, not recruitingOBSERVATIONAL

Enrollment

1,300

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2035

Conditions

Atrial Fibrillation

Trial Locations (1)

44145

Cleveland Clinical Foundation, Cleveland

All Listed Sponsors

lead

The Cleveland Clinic

OTHER